Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (Q4)Feb 28, 2025 | (Q3)Nov 30, 2024 | (Q2)Aug 31, 2024 | (Q1)May 31, 2024 | (FY)Feb 29, 2024 | (Q4)Feb 29, 2024 | (Q3)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.69%90.04M | -25.99%82.94M | 22.97%418.32M | -7.94%98.76M | 16.87%104.36M | 41.11%103.13M | 58.93%112.07M | 68.41%340.18M | 36.13%107.28M | 86.18%89.3M |
| Cost of revenue | -11.88%69.75M | -27.89%64.25M | 30.66%324.81M | -5.32%72.34M | 25.30%83.09M | 45.81%79.16M | 72.82%89.11M | 72.36%248.58M | 39.44%76.41M | 88.64%66.32M |
| Gross profit | -15.35%20.29M | -18.62%18.69M | 2.10%93.52M | -14.43%26.41M | -7.46%21.27M | 27.56%23.97M | 21.15%22.97M | 58.53%91.6M | 28.59%30.87M | 79.44%22.98M |
| Operating expense | 95.85%4.43M | -25.83%5.17M | -27.31%22.1M | -0.18%7.62M | -8.75%6.38M | -74.88%2.26M | 3.60%6.97M | 67.43%30.41M | 4.02%7.63M | 5.47%7M |
| Selling and administrative expenses | -16.15%6.04M | -17.54%5.69M | -10.41%27.37M | 1.41%7.69M | -5.95%6.68M | -19.57%7.2M | -0.17%6.89M | 6.25%30.55M | -4.39%7.59M | 7.18%7.11M |
| -Selling and marketing expense | -29.58%1.22M | -5.42%1.55M | -9.59%6.21M | -6.10%1.42M | -12.56%1.39M | -19.27%1.73M | 0.74%1.64M | 4.42%6.87M | -6.40%1.51M | -2.04%1.59M |
| -General and administrative expense | -11.88%4.81M | -21.32%4.13M | -10.65%21.16M | 3.27%6.28M | -4.06%5.3M | -19.66%5.46M | -0.45%5.25M | 6.79%23.68M | -3.87%6.08M | 10.15%5.52M |
| Other operating expenses | -74.94%789K | -19.88%794K | 72.55%5.99M | 9.72%982K | 3.62%888K | 239.33%3.15M | 25.13%991K | -0.74%3.47M | 6.80%895K | 7.93%857K |
| Total other operating income | -70.41%2.39M | 42.76%1.31M | 211.72%11.25M | 24.53%1.06M | 22.73%1.19M | 832.30%8.08M | -5.65%919K | -74.37%3.61M | -40.86%848K | 22.22%968K |
| Operating profit | -26.94%15.86M | -15.48%13.52M | 16.71%71.41M | -19.11%18.79M | -6.89%14.89M | 121.92%21.71M | 30.80%16M | 54.45%61.19M | 39.41%23.23M | 158.87%15.99M |
| Net non-operating interest income (expenses) | -69.98%-957K | 12.87%-711K | 15.20%-2.91M | 9.26%-774K | -2.31%-753K | 37.37%-563K | 13.10%-816K | -34.39%-3.43M | -1.43%-853K | 9.25%-736K |
| Non-operating interest expense | 69.98%957K | -12.87%711K | -15.20%2.91M | -9.26%774K | 2.31%753K | -37.37%563K | -13.10%816K | 34.39%3.43M | 1.43%853K | -9.25%736K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -153.19%-25K | 47K | ||||||||
| Less:Write off | ---- | ---- | 153.19%25K | ---- | ---- | ---- | ---- | ---47K | ---- | ---- |
| Other non-operating income (expenses) | ||||||||||
| Income before tax | -29.52%14.9M | -15.62%12.81M | 18.46%68.48M | -19.48%18.02M | -7.34%14.13M | 138.04%21.14M | 34.45%15.19M | 55.96%57.81M | 41.43%22.38M | 184.29%15.25M |
| Income tax | -16.67%3.64M | -18.86%3.58M | 17.46%19.35M | -20.32%4.96M | 15.92%5.62M | 64.48%4.37M | 60.45%4.41M | 87.77%16.48M | 45.36%6.23M | 132.77%4.84M |
| Net income | -32.87%11.26M | -14.30%9.24M | 18.86%49.13M | -19.16%13.06M | -18.16%8.52M | 169.41%16.78M | 26.10%10.78M | 46.09%41.33M | 39.97%16.15M | 216.93%10.41M |
| Net income continuous operations | -32.87%11.26M | -14.30%9.24M | 18.86%49.13M | -19.16%13.06M | -18.16%8.52M | 169.41%16.78M | 26.10%10.78M | 46.09%41.33M | 39.97%16.15M | 216.93%10.41M |
| Noncontrolling interests | -6.71%1.81M | 16.99%1.57M | -11.56%5.25M | -52.42%766K | -28.77%1.2M | 115.33%1.94M | -22.74%1.34M | 173.66%5.93M | 516.86%1.61M | 64.65%1.69M |
| Net income attributable to the company | -36.29%9.45M | -18.75%7.67M | 23.96%43.88M | -15.47%12.29M | -16.11%7.32M | 178.54%14.84M | 38.56%9.44M | 35.51%35.4M | 28.94%14.54M | 285.93%8.72M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -36.29%9.45M | -18.75%7.67M | 23.96%43.88M | -15.47%12.29M | -16.11%7.32M | 178.54%14.84M | 38.56%9.44M | 35.51%35.4M | 28.94%14.54M | 285.93%8.72M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -36.21%0.0643 | -20.94%0.0521 | 8.89%0.3002 | -25.58%0.0835 | -27.02%0.0497 | 142.31%0.1008 | 23.87%0.0659 | 35.08%0.2757 | 27.36%0.1122 | 284.75%0.0681 |
| Diluted earnings per share | -36.21%0.0643 | -20.94%0.0521 | 8.89%0.3002 | -25.58%0.0835 | -27.02%0.0497 | 142.31%0.1008 | 23.87%0.0659 | 35.08%0.2757 | 27.36%0.1122 | 284.75%0.0681 |
| Dividend per share | 0.00%0.022 | 0 | 46.67%0.022 | 0 | 0 | 46.67%0.022 | 0 | -16.67%0.015 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.